We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Report Discusses POC Testing and Changing Paradigms

By LabMedica International staff writers
Posted on 20 Jun 2017
The American Academy of Microbiology has released a new report on the role of the role of point-of-care (POC) and near-patient testing in changing diagnostic paradigms in microbiology.

Technology for diagnosing infectious diseases in patients is rapidly advancing, and new diagnostic tests have the potential to meaningfully improve patient care. More...
Recommendations for the Academy’s report (Changing Diagnostic Paradigms for Microbiology, published May 2017) were based on discussions of a panel of experts. The Academy convened a colloquium October 17-18, 2016, (Washington, DC; USA) to explore the development and implementation of near-patient and POC testing and to provide recommendations for using these tests to improve patient care across clinical settings.

“Rapid diagnostic tests have the potential to deliver timely results, enable treatment decisions by detecting the presence of biomarkers, distinguish between viral and bacterial infections, identify causative organisms, and provide information on drug resistance,” said Melissa Miller, PhD, steering committee chair of the colloquium. The report focuses on the unmet needs for research and development of new diagnostic tests, for ongoing regulatory review of POC tests, and for laboratorian expertise, even in near-patient settings. The participants also discussed the importance of proper interpretation of test results, and linking test results to electronic medical records. They emphasized the need for microbiology experts to guide the development and utilization of tests and ensure proper reporting of results.

“The expertise of clinical microbiologists is essential to maximizing the value and minimizing the risk of POC infectious disease diagnostics, provided that clinical microbiologists adapt their practice to this setting,” said Sheldon Campbell, MD, PhD, Yale School of Medicine, a participant in the colloquium.

The report summarized proper utilization of tests (such as ordering appropriate tests and correctly interpreting results), the need for proper training and education on test usage, and contamination concerns. It also discussed regulation of the tests (reporting issues to FDA, CMS requirements), and the importance of documenting results and reporting to health departments when necessary. For the future, participants agreed that POC tests should be linked to web-based quality and performance matrices that would revolutionize POC testing quality and reach.

A commentary with additional information on advances in diagnostics, Advances Afoot in Microbiology by Mayo Clinic’s Patel R and Karon BS, was published May 24, 2017, in the Journal of Clinical Microbiology.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Urinalysis Solution
UN-9000
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Blood Protein Analysis Reveals Menopause-Associated Signals of Brain Aging

Menopause affects women across midlife and is often accompanied by endocrine changes, hot flashes, brain fog and sleep disturbances. Women spend roughly one third of their lives after the menopause transition,... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI-Supported Approach May Improve Cervical Cancer Screening in Low-Resource Settings

Cervical cancer screening coverage often remains below 15% in low- and middle-income countries. Limited accuracy of visual inspection with acetic acid, together with uneven access to high-quality human... Read more

Hematology

view channel
Image: Mayo Clinic researchers used genetic data from nearly 50,000 participants to identify sickle cell and beta-thalassemia carrier traits, highlighting how population-scale testing can complement existing screening (Image Credit: Adobe Stock)

Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification

Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: SG-INSIGHT study will extend whole- genome sequencing to nearly 1 in 10 Singapore residents, generating evidence to inform how precision medicine could be implemented in Singapore’s healthcare system. (Photo courtesy of Precision Health Research, Singapore)

Illumina Selected to Support National Genomics Study for Personalized Healthcare in Singapore

Singapore’s National Precision Medicine program is using genomic and health data to support more preventive and personalized healthcare. Its latest phase expands beyond healthy volunteers to people with... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.